Gain Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Gain Therapeutics, Inc.

Welcome to our dedicated page for Gain Therapeutics, Inc. (Nasdaq: GANX) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Gain Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Gain Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for GANX
TickerTime & DateFilingLink
GANX9:23:31 PM, 8/12/2024
Mack Gene(CFO and Interim CEO) purchased 14400 shares of Gain Therapeutics, Inc. (GANX) for ~$14544
Filing
GANX9:23:30 PM, 8/12/2024
Islam Khalid(Executive Chairman) purchased 50000 shares of Gain Therapeutics, Inc. (GANX) for ~$50000
Filing
GANX9:00:27 PM, 7/1/2024
RICHMAN ERIC I purchased 17000 shares of Gain Therapeutics, Inc. (GANX) for ~$20670
Filing
GANX8:01:37 PM, 4/1/2024
Riley Jeffrey Scott purchased 30000 shares of Gain Therapeutics, Inc. (GANX) for ~$115800
Filing
GANX9:17:28 PM 12/22/2023
Alder Matthias(Chief Executive Officer) sold 206 shares of Gain Therapeutics, Inc. (GANX) for ~$506
Filing
GANX9:01:11 PM 12/14/2023
Alder Matthias(Chief Executive Officer) sold 1820 shares of Gain Therapeutics, Inc. (GANX) for ~$4550
Filing